Assignee
SCHERING AG
DE1,398 patents
Top patents by PatentIndex Score
US6454743B1Sep 24, 2002
Injection device
SCHERING AG276 citations99
US5789442AAug 4, 1998
Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
SCHERING AG135 citations99
US4957939ASep 18, 1990
Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
SCHERING AG141 citations99
US4647447AMar 3, 1987
Diagnostic media
SCHERING AG612 citations99
US6207665B1Mar 27, 2001
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG89 citations98
US5676968AOct 14, 1997
Transdermal therapeutic systems with crystallization inhibitors
SCHERING AG162 citations98
US5425366AJun 20, 1995
Ultrasonic contrast agents for color Doppler imaging
SCHERING AG358 citations98
US5410516AApr 25, 1995
Ultrasonic processes and circuits for performing them
SCHERING AG267 citations98
US5021236AJun 4, 1991
Method of enhancing NMR imaging using chelated paramagnetic ions bound to biomolecules
SCHERING AG381 citations98
US4975159ADec 4, 1990
Aqueous acidic bath for electrochemical deposition of a shiny and tear-free copper coating and method of using same
SCHERING AG141 citations98
US4681119AJul 21, 1987
Method of production and use of microbubble precursors
SCHERING AG294 citations98
US4657756AApr 14, 1987
Microbubble precursors and apparatus for their production and use
SCHERING AG397 citations98
US4442843AApr 17, 1984
Microbubble precursors and methods for their production and use
SCHERING AG381 citations98
US4364921ADec 21, 1982
Novel triiodinated isophthalic acid diamides as nonionic X-ray contrast media
SCHERING AG176 citations98
US3960949AJun 1, 1976
1,2-Biguanides
SCHERING AG175 citations98
US6958327B1Oct 25, 2005
18 Norsteroids as selectively active estrogens
SCHERING AG88 citations97
US5501863AMar 26, 1996
Contrast media synthesized from polyaldehydes
SCHERING AG179 citations97
US4136145AJan 23, 1979
Medicament carriers in the form of film having active substance incorporated therein
SCHERING AG354 citations97
US4136162AJan 23, 1979
Medicament carriers in the form of film having active substance incorporated therein
SCHERING AG267 citations97
US7488468B1Feb 10, 2009
Near infrared fluorescent contrast agent and fluorescence imaging
SCHERING AG56 citations96
US6356777B1Mar 12, 2002
Methods of and apparatus for activating the muscle cells or nerves of the uterus or cervix
SCHERING AG56 citations96
US6323199B1Nov 27, 2001
Nonsteroidal anti-inflammatory agents
SCHERING AG95 citations96
US6177062B1Jan 23, 2001
Agents and methods for enhancing contrast in ultrasound imaging
SCHERING AG76 citations96
US6114321ASep 5, 2000
Porphyrin derivatives, pharmaceutical agents that contain the latter, and their use in photodynamic therapy and MRI diagnosis
SCHERING AG57 citations96
US6071496AJun 6, 2000
Polyalkylcyanoacrylate agents and methods for enhancing contrast in ultrasound imaging
SCHERING AG74 citations96
US6040340AMar 21, 2000
Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
SCHERING AG86 citations96
US5922349AJul 13, 1999
Hormone replacement therapy method and hormone dispenser
SCHERING AG117 citations96
US5876698AMar 2, 1999
Macrocyclic polymer complexing agents, their complexes, process for their production and pharmaceutical agents containing these compounds
SCHERING AG65 citations96
US5820849AOct 13, 1998
Cascade polymer complexes, process for their production and pharamceutical agents containing said complexes
SCHERING AG73 citations96
US5733902AMar 31, 1998
Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors
SCHERING AG84 citations96
US5719136AFeb 17, 1998
Combination of progesterone antagonists and antiestrogens with partial agonistic action for hormone substitution therapy for perimenopausal and postmenopausal women
SCHERING AG114 citations96
US5693310ADec 2, 1997
Amide complexes
SCHERING AG152 citations96
US5650136AJul 22, 1997
Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
SCHERING AG39 citations96
US5569652AOct 29, 1996
Dihydrospirorenone as an antiandrogen
SCHERING AG80 citations96
US5446035AAug 29, 1995
20-methyl-substituted vitamin D derivatives
SCHERING AG79 citations96
US5385943AJan 31, 1995
Use of topically applicable preparations for treatment of presbyderma
SCHERING AG140 citations96
US5364614ANov 15, 1994
Cascade polymer bound chelating compounds, their chelates and conjugates, processes for their production, and pharmaceutical agents containing them
SCHERING AG60 citations96
US5362475ANov 8, 1994
Gadolinium chelates for magnetic resonance imaging
SCHERING AG81 citations96
US5277895AJan 11, 1994
Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives, process for their production and pharmaceutical agents containing these derivatives
SCHERING AG48 citations96
US5141738AAug 25, 1992
Ultrasonic contrast medium comprising gas bubbles and solid lipophilic surfactant-containing microparticles and use thereof
SCHERING AG267 citations96
US5089488AFeb 18, 1992
β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same
SCHERING AG44 citations96
US4814327AMar 21, 1989
11 β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same
SCHERING AG49 citations96
US4738957AApr 19, 1988
Estriol esters
SCHERING AG79 citations96
US4609651ASep 2, 1986
11β-arylestradienes, their production, and pharmaceutical preparations containing same
SCHERING AG67 citations96
US4567195AJan 28, 1986
Azaprostacyclins, their preparation and pharmaceutical use
SCHERING AG59 citations96
US4209613AJun 24, 1980
Process for the preparation of nucleosides
SCHERING AG107 citations96
US4153713AMay 8, 1979
4-(Polyalkoxyphenyl)-2-pyrrolidones (II)
SCHERING AG65 citations96
US4082911AApr 4, 1978
Process for the preparation of nucleosides
SCHERING AG65 citations96
US7235561B2Jun 26, 2007
Compound and a composition including such a compound
SCHERING AG58 citations95
US7129254B2Oct 31, 2006
Effector conjugates, process for their production and their pharmaceutical use
SCHERING AG51 citations95
Showing the top 50 of 1,398 patents by PatentIndex Score.